07:00 , Oct 17, 2011 |  BioCentury  |  Finance

First in fall

Cempra Holdings LLC is the first U.S. biotech to propose an IPO since July. The antibiotics company, which filed to raise $86.3 million, hopes to use the funds for Phase III testing of two candidates...
07:00 , May 19, 2008 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Cempra Pharmaceuticals Inc. Chapel Hill, N.C. Technology: Macrolide antibiotics against resistant bacteria Disease focus: Infectious, gastrointestinal and inflammation Clinical status: Phase I Founded: 2006 by Prabhavathi Fernandes, E. Cali Downs, Michael Dombeck and Cindy Ingram...